Conventional cancer therapies are restrained by morbid off-target effects and the frequent
emergence of chemotherapy drug resistance. These limitations have motivated advances in …

Recent years have witnessed dramatic improvements in nanotechnology-based cancer
therapeutics, and it continues to evolve from the use of conventional therapies …

Bravo, M. ab, Fortuni, B. b, Mulvaney, P. a, Hofkens, J. b, d, Uji-i, H. ac, Rocha, S. b*,
Hutchison, J. a* a ARC Centre of Excellence in Exciton Science, School of Chemistry …

Nanotechnology has enabled the development of smart theranostic platforms that can
concurrently diagnose disease, start primary treatment, monitor response, and, if required …

Externally modulated nanoparticles comprise a rapidly advancing class of cancer
nanotherapeutics, which combine the favorable tumor accumulation of nanoparticles, with …

Although cancer treatment has improved dramatically over recent decades, it continues to
remain among the most challenging public health issues. Comprehensive cancer …

Cancer is a complex disease, dominantly treated with chemotherapy, which has limitations
such as lack of specificity, cytotoxicity, and the induction of drug resistance, amongst others …

Cancer treatment has yet to find a “silver bullet” capable of selectively and effectively kill
tumor cells without damaging healthy cells. Nanomedicine is a promising field that can …

Nanocarriers for cancer therapy have been extensively studied, but there is still some
research that must be addressed in order to achieve their safe application. In this field …

Nanomaterials have revolutionized cancer imaging, diagnosis, and treatment.
Multifunctional nanoparticles in particular have been designed for targeted cancer therapy …